SCHEMBL8199557

SCHEMBL8199557

O=C(O)c1oc2ccc(Cl)cc2c1-c1ccccc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 3/20 0.57
KDM4E B2RXH2 4/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
MAPK1 P28482 1/20 0.51
PIM1 P11309 1/20 0.47
CSNK2A2 P19784 1/20 0.47
CSNK2B P67870 1/20 0.47
PIM3 Q86V86 1/20 0.47
PIM2 Q9P1W9 1/20 0.47
MAOA P21397 1/20 0.47
ALDH1A1 P00352 5/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 2/20 0.47
TTR P02766 2/20 0.46
AHR P35869 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
ADORA3 P0DMS8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8200416 0.86 PIM1 (0.49) MCL1KDM4EMEN1KMT2AMAPK1
SCHEMBL6940805 0.86 MCL1 (0.62) MCL1KDM4EMEN1KMT2AMAPK1
SCHEMBL8189192 0.86 GABRP (0.55) MCL1KDM4EMEN1KMT2AMAPK1
SCHEMBL8200379 0.86 MAPT (0.42) MCL1KDM4EMEN1KMT2AMAPK1
SCHEMBL9220776 0.85 KMT2A (0.46) MCL1KDM4EMEN1KMT2APIM1
SCHEMBL8401426 0.84 MCL1 (0.61) MCL1KDM4EMEN1KMT2AMAPK1
SCHEMBL8398928 0.83 MCL1 (0.51) MCL1KDM4EMEN1KMT2AMAPK1
SCHEMBL8197642 0.83 THRB (0.44) MCL1MEN1KMT2AALDH1A1HPGD
SCHEMBL8196770 0.83 MCL1 (0.54) MCL1KDM4EMEN1KMT2AMAPK1
SCHEMBL8189205 0.83 KDM4E (0.52) KDM4EMEN1KMT2APIM1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3753560-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2020-12-23 EP claimed
EP-3753560-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2020-12-23 EP disclosed
EP-3753560-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2020-12-23 EP disclosed
US-RE36832-E AN ANTICHOLESTEROL AGENT TREATING HYPERCHOLESTEROLEMIA NIHON NOHYAKU CO., LTD (JP) 2000-08-22 US disclosed
EP-0613894-B1 N-Heteroaryl-N'-phenylurea derivatives, their production and use NIHON NOHYAKU CO LTD (JP) 1999-05-06 EP disclosed
US-5464863-A Anticholesterol agents NIHON NOHYAKU CO., LTD. (JP) 1995-11-07 US disclosed
EP-0613894-A1 N-Heteroaryl-N'-phenylurea derivatives, their production and use NIHON NOHYAKU CO., LTD. (JP) 1994-09-07 EP disclosed